According to Medistim's latest financial reports the company's current EPS (TTM) is $0.94. In 2023 the company made an earnings per share (EPS) of $0.95 a decrease over its 2022 EPS that were of $1.09.
Year | EPS | Change |
---|---|---|
2024 (TTM) | $0.91 | -3.65% |
2023 | $0.95 | -12.65% |
2022 | $1.09 | 12.85% |
2021 | $0.96 | 26.94% |
2020 | $0.76 | 1.75% |
2019 | $0.74 | 21.73% |
2018 | $0.61 | 12.93% |
2017 | $0.54 | 28.21% |
2016 | $0.42 | -1.91% |
2015 | $0.43 | 8.85% |
2014 | $0.40 | -3.68% |
2013 | $0.41 | -18.65% |
2012 | $0.51 | 109.16% |
2011 | $0.24 | -18.07% |
2010 | $0.29 | -33.5% |
2009 | $0.44 | 139.28% |
2008 | $0.19 | -60.7% |
2007 | $0.47 | 81.99% |
2006 | $0.26 | 63.49% |
2005 | $0.16 | 20.58% |
2004 | $0.13 |